DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194118

Knowledge, attitude and practice regarding generic drugs and branded drugs: a cross sectional study

Gyanendra Kumar, Aditi Garg, Jatinder Kaur Dhillon, Arshad Eranhikkal, Manjakandi Smitha

Abstract


Background: Medicines play a main role in the process of human development. The rational utilization of medicines can decrease morbidity and mortality as well as improve quality of life. In an era of steeply rising health care expenses, generic medicines provide a less expensive alternative to branded medicines. Use of generic drugs can contribute to substantial savings in medicines expenditure and the issue of access and affordability is thus addressed.

Methods: A sample of 500 patients selected from out patient department was randomly selected. A self-instructed questionnaire was used for the study for the duration of 1 month. Data was analyzed using IBM SPSS statistics Version 20 New York, United States. Summary statistics were expressed using mean and standard deviation (SD) for numerical variables (median and interquartile ranges [IQRs] when skewed) and counts and percentages for categorical variables.

Results: Participants reported with 17.23% knowledge score, 40.65% attitude score, and 7.96% attitude score.

Conclusions: In the study it was found that there is significant correlation between knowledge and attitude whereas no correlation was found between knowledge and practice regarding usage of generic drugs.


Keywords


Branded drugs, Generic drugs, Non-proprietary, Proprietary, Multinational companies, Prescriptions

Full Text:

PDF

References


Andersson K, Bergström G, Petzold MG, Carlsten A. Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals. Health Policy. 2007;81:376–84.

National Association of Pharmaceutical Manufacturers (NAPM). The generic pharmaceutical market in South Africa: At the cross roads? J Generic Med. 2009;6:377–44.

King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economics. Croat Med J. 2002;43(4):462-9

Chua GN, Hassali AM, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95:229-5.

Bakthavathsalam G. Generic drugs: Cost effective alternative to branded drugs. Health Adm. 2009;9(1):16-9.

Olusola AM, Olubukola OO, Emeka OH, Lilian AE. Equivalence of two generic brands of amlodipine besylate under biowaiver conditions. Int J Pharmacy Pharm Sci. 2012;4(2):265-8.

Bulsara C, McKenzie A, Sanfilippo F, Holman CD, Emery JE. 'Not the full Monty': A qualitative study of seniors’ perceptions of generic medicines in Western Australia. Aust J Prim Health. 2010;16:240–5.

Akici A, Aydin V, Mollahaliloglu S, Ozgulcu S, Alkan A. Evaluation of the attitudes of specialist and family physicians regarding rational drug selection. North Clin Istanb. 2009;5(3):199–206.

Cheung WY, Kornelsen EA, Mittmann N. The economic impact of the transition from branded to generic oncology drugs. Curr Oncol. 2019;26(2):89–93.